Growth Drivers for Biomarkers in Healthcare
The global biomarkers market was estimated at $ billion in 2014 and is expected to reach $ billion in 2020, growing at a robust CAGR of % (2014–2020).
North America is the highest revenue-generating region with $ billion revenue in 2014, accounting for % of the total global biomarkers market.
Genomics is the highest revenue-generating segment with a revenue of $ billion in 2014, accounting for % of the total global biomarkers market. The segment is expected to grow at a CAGR of % (2014–2020).
The Asia-Pacific region will experience the highest growth rate in the forecast period, outpacing other regions, with a CAGR of % (2014–2020).
Currently, the adoption of genomics- and proteomics-based biomarkers is the highest, with a number of novel lipidomics and immunomics markers coming to the fore.
Developments in the ‘omics’ platforms, such as glycomics, lipidomics, and immunomics, are paving way for the discovery of potentially useful biomarkers that can be used for early diagnosis, prognosis, and drug development.
About this report
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological platforms in biomarkers discovery, validation and development in the drug discovery and development market globally. The research study addresses the major issues and challenges, unmet needs and emerging market & technological trends. The report also outlines market drivers and restraints, recent research and developments, Key Innovations and Companies to watch etc.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook